CCR2 and neoplasm: In addition, there was a decrease of circulatory CCR2+ monocytes, an increase of bone marrow CCR2+ monocytes, a reduction of TAMs in tumor tissues and modulation of the TME (increase in IL-12 and TGF-α, and a decrease in IL-10, TGF-b, IL-13) (154).